Reporting Status% of public hospitals reporting to HMIS<2071/72>92<2072/73>89<2073/74>93 Reporting Status% of primary health care centres reporting to HMIS<2071/72>99<2072/73>100<2073/74>98 Reporting Status% of health posts reporting to HMIS<2071/72>99<2072/73>99<2073/74>100 Reporting Status% of PHC-ORC clinics reporting to HMIS<2071/72>81<2072/73>92<2073/74>89 Reporting Status% of EPI clinics reporting to HMIS<2071/72>92<2072/73>88<2073/74>100 Reporting Status% of female community health volunteers (FCHVs) reporting to HMIS<2071/72>87<2072/73>82<2073/74>90 Reporting Status% of private health facilities reporting to HMIS<2071/72>68<2072/73>80<2073/74>47 Immunization% of children under one year immunized with BCG<2071/72>94<2072/73>87<2073/74>91 Immunization% of children under one year immunized with DPT-HepB-Hib3<2071/72>91<2072/73>82<2073/74>86 Immunization% of children under one year immunized with OPV 3<2071/72>90<2072/73>79<2073/74>86 Immunization% of one-year- old children immunized against measles/rubella<2071/72>85<2072/73>77<2073/74>84 Immunization% of children 12- 23 months immunized against Japanese encephalitis<2071/72>53<2072/73>63<2073/74>67 ImmunizationImmunization programme: Dropout rate DPT-Hep B-Hib 1 vs 3 coverage<2071/72>3.2<2072/73>5<2073/74>4.7 Nutrition% of children aged 0-12 months registered for growth monitoring<2071/72>97<2072/73>78<2073/74>85 NutritionAverage number of visits among children aged 0- 24 months registered for growth monitoring<2071/72>3<2072/73>3<2073/74>3 Nutrition% of children aged 0- 6 months registered for growth monitoring, exclusively breastfed for the first six months<2071/72>29<2072/73>32<2073/74>25 Nutrition% of children aged 6–8 months registered for growth monitoring received solid, semi-solid or soft foods<2071/72>28<2072/73>32<2073/74>31 Nutrition% of children aged 6-23 months, who received 1st dose of Baal Vita (MNP) in 15 programme districts<2071/72>19<2072/73>21<2073/74>34 NutritionPercentage of children aged 0-<2071/72>78<2072/73>64<2073/74>69 Nutrition23 months registered for growth monitoring<2071/72> -<2072/73> -<2073/74> - NutritionPercentage of pregnant women received 180 tablets Iron<2071/72>52<2072/73>49<2073/74>44 Acute Respiratory Infection(ARI)Incidence of acute respiratory infection (ARI) per 1,000 children under five years (new visits)<2071/72>765<2072/73>648<2073/74>612 Acute Respiratory Infection(ARI)Incidence of pneumonia among children under five years (per 1,000) Note*= HFs reporting only<2071/72>188<2072/73>147<2073/74>66 Acute Respiratory Infection(ARI)% of children under five years with ARI suffering pneumonia<2071/72>25<2072/73>22<2073/74>10 Acute Respiratory Infection(ARI)Percentage of severe Pneumonia among new U5 yrs cases<2071/72>0.4<2072/73>0.3<2073/74>0.3 DiarrhoeaIncidence of diarrhoea per 1,000 under five years children (new cases)<2071/72>502<2072/73>422<2073/74>400 Diarrhoea% of children under 5 with diarrhoea treated with zinc and ORS<2071/72>93<2072/73>87<2073/74>92 Diarrhoea% of children under five years with diarrhoea treated with IV fluid<2071/72>0.64<2072/73>0.8<2073/74>0.7 DiarrhoeaPercentage of children U5 years with<2071/72>0.3<2072/73>0.2<2073/74>0.4 Diarrhoeadiarrhoea suffering from Severe dehydration<2071/72> -<2072/73> -<2073/74> - DiarrhoeaPercentage of children U5 years with Pneumonia treated with antibiotics<2071/72>189<2072/73>174<2073/74>156 Safe Motherhood% of pregnant women who received Td 2 and 2+<2071/72>52<2072/73>66<2073/74>64 Safe Motherhood% of pregnant women attending first ANC visit<2071/72>96<2072/73>97<2073/74>102 Safe Motherhood% of pregnant women attending four ANC visits<2071/72>52<2072/73>51<2073/74>53 Safe Motherhood% of pregnant women receiving IFA tablets or syrup during their last pregnancy<2071/72>52<2072/73>49<2073/74>40 Safe Motherhood% of postpartum mothers who received vitamin A supplements<2071/72>49<2072/73>51<2073/74>72 Safe Motherhood% of institutional deliveries<2071/72>52<2072/73>55<2073/74>55 Safe Motherhood% of deliveries conducted by a skilled birth attendant<2071/72>51<2072/73>54<2073/74>52 Safe Motherhood% of postpartum women received PNC checkup within 24 hours of birth<2071/72>48<2072/73>52<2073/74>51 Safe Motherhood% of women who had three PNC check-ups as per protocol<2071/72>20<2072/73>18<2073/74>19 Family PlanningFP Methods New acceptor among as % of MWRA<2071/72>11<2072/73>11<2073/74>10 Family PlanningContraceptive prevalence rate (CPR- unadjusted)<2071/72>43<2072/73>43<2073/74>36 Family PlanningCPR method mix – condoms<2071/72>3.5<2072/73>3.5<2073/74>3 Family PlanningCPR method mix - pills<2071/72>3<2072/73>3<2073/74>2.5 Family PlanningCPR method mix - Depo<2071/72>6.9<2072/73>6.7<2073/74>6 Family PlanningCPR method mix - IUCD<2071/72>2.6<2072/73>2.7<2073/74>2.3 Family PlanningCPR method mix - implants<2071/72>2.8<2072/73>4<2073/74>3.8 Family PlanningCPR method mix - sterilization<2071/72>23.8<2072/73>22.5<2073/74>18.5 Family PlanningSterilization (Tar vs Achiev.)<2071/72>62<2072/73>78<2073/74>77 Female Community Health Volunteers(FHCV)Total number of FCHVs (Note =*= HMIS source)<2071/72>51470<2072/73>51416<2073/74>49101 Female Community Health Volunteers(FHCV)% of ARI cases managed by FCHVs among ARI cases in children under five years<2071/72>57<2072/73>41<2073/74>59 Female Community Health Volunteers(FHCV)% of mothers group meeting<2071/72>100<2072/73>94<2073/74>86 Female Community Health Volunteers(FHCV)% of PHC/ ORC conducted among planned PHC/ORC<2071/72>84<2072/73>82<2073/74>89 Malaria and kala-azarMalaria Blood Slide collection( target vs achieve )<2071/72>69<2072/73>78<2073/74>77 Malaria and kala-azarMalaria Slide examination (collection vs. exam.)<2071/72>126<2072/73>112<2073/74>101 Malaria and kala-azarAnnual blood slide examination rate (ABER) per 100<2071/72>0.75<2072/73>0.84<2073/74>0.79 Malaria and kala-azarAnnual parasite incidence (API) per 1,000<2071/72>0.1<2072/73>0.07<2073/74>0.08 Malaria and kala-azarpopulation at risk<2071/72 /><2072/73> -<2073/74> - Malaria and kala-azarClinical malaria cases<2071/72>20861<2072/73>10642<2073/74>3904 Malaria and kala-azarIncidence of kala-azar per 10,000 population at risk<2071/72>0.25<2072/73>0.12<2073/74>0.11 TuberculosisCase notification rate (all forms of TB)<2071/72>123<2072/73>113<2073/74>111 TuberculosisTreatment success rate<2071/72>92<2072/73>90<2073/74>91 LeprosyNew case detection rate (NCDR) per 100,000 population<2071/72>11<2072/73>11<2073/74>11 LeprosyPrevalence rate (PR) per 10,000<2071/72>0.9<2072/73>0.9<2073/74>0.9 HIV/AIDs STINumber of HIV testing<2071/72>264081<2072/73>122888<2073/74>176228 HIV/AIDs STINumber of new positive cases<2071/72>1480<2072/73>2163<2073/74>1781 HIV/AIDs STI% of positivity yield<2071/72>0.6<2072/73>1.8<2073/74>1 Curative Services% of population utilizing outpatient (OPD) services<2071/72>73<2072/73>66<2073/74>72 Curative ServicesAverage length of stay<2071/72>3<2072/73>4<2073/74>3